Graciela S. Alarcon
Graciela S. Alarcón graduated from Universidad Peruana Cayetano Heredia (UPCH) in Lima, Peru, and completed her internal medicine and rheumatology training at Baltimore City Hospitals and Johns Hopkins, Md, USA, where she also received an M.S. degree in public health. In Peru (1972), she created a Rheumatology Unit at UPCH. She returned to the USA in 1980 (University of Alabama at Birmingham, UAB) and became an endowed Professor of medicine in 1998. Dr. Alarcón, with Drs. Reveille and Vilá, has led frontline research on lupus among minority groups in the USA. The LUMINA cohort study has placed Lupus among Hispanics on the map and has shown that poverty, not ethnicity, is an important explanatory factor for a diminished survival among minority patients and that patients treated with hydroxychloroquine accrue less damage and reach better survival. Dr. Alarcón has provided clinical research training, focused on Lupus, to young Hispanic/Latino rheumatologists. As an Emeritus Member of the UAB Faculty (since 2009), Dr. Alarcón is supervising the work of her former fellows. She has been recognized by PANLAR and the ACR as master of these institutions, a distinction that she shares with a selected number of colleagues. Dr. Alarcón has received many other distinctions and authored over 400 articles, is a Referee for several journals [Arthritis and Rheumatism (A&R), Arthritis Care and Research (ACR), Rheumatology, Journal of Rheumatology, Journal of Clinical Rheumatology, Clinical Rheumatology, Arthritis Research and Therapy, Seminars in Arthritis and Rheumatism, Annals of Internal Medicine (AIM), American Journal of Medicine (AJM), New England Journal of Medicine, Pain, Clinical Journal of Pain, among others), and has been an Editor or a Member of the Editorial Board for A&R, ACR, AIM, and AJM. She is also a Member of the Scientific Board of the Lupus Foundation of America and an Advisor to the Lupus Clinical Trials Consortium.
Biography Updated on 16 October 2011